Alkermes: FDA panel will review Vivitrol in Sept.

Alkermes: FDA panel will review Vivitrol in Sept.
Drug developer Alkermes Inc. said Thursday a Food and Drug Administration committee will meet to review a possible new approved use for its addiction drug Vivitrol in September.

Read more on AP via Yahoo! Finance